Back to search results
Joseph Sabatino
5.0 out of 5 (69)
Joseph Sabatino

Joseph Sabatino, MD, PhD

Neurology

Multiple Sclerosis and Neuroinflammation Center
1651 Fourth St., Suite 252,
San Francisco, CA 94158
(415) 353-2069
5.0 out of 5 (69)
Virtual visits available
5.0 out of 5 (69)
Virtual visits available
Multiple Sclerosis and Neuroinflammation Center
1651 Fourth St., Suite 252,
San Francisco, CA 94158
(415) 353-2069

Dr. Joseph Sabatino Jr. is a neurologist with expertise in caring for patients who have multiple sclerosis, neuromyelitis optica (a neurological disorder that primarily affects the optic nerves and spinal cord) and other neuroinflammatory disorders (conditions in which immune responses lead to nervous system damage).

Sabatino's research focuses on T-cell immunology in multiple sclerosis and similar disorders.

Sabatino earned his medical degree and doctorate at the Emory University School of Medicine. He completed a residency in neurology at the Johns Hopkins Hospital, followed by a fellowship in multiple sclerosis and neuroimmunology at UCSF.

  • Board Certifications

    American Board of Psychiatry and Neurology, Neurology, 2016

  • Fellowships

    UCSF, Neuroimmunology, 2019

  • Residencies

    Johns Hopkins University School of Medicine, Neurology, 2016

  • Internship

    Johns Hopkins Bayview Medical Center - GME, Internal Medicine, 2013

  • Education

    Emory University School of Medicine, 2012

  • Languages

    English

My passions are caring for patients and engaging in research that will hopefully help us provide better treatments for everyone.

Conditions I specialize in

Where I see patients (1)

    My reviews

    5.0

    Overall Experience
    69 Ratings
    About our process
    Mar 28, 2025
    Dr Sabatino is a good doctor. He listens, thinks & responds with great information. As a patient I appreciate him greatly.
    Feb 21, 2025
    Always say UCSF should be a model for Every health system!!!
    Jan 02, 2025
    Dr. Sabatino continues to provide an excellent understanding and explanation of the diagnosis and available treatment modalities for my conditions. His demonstration of genuine sensitivity to my concerns provides great comfort.
    Nov 11, 2024
    He's very knowledgeable caring and eager to help
    Oct 22, 2024
    Dr. Sabatino is not only highly knowledgeable in his field, but he is also an exceptional doctor who genuinely cares for his patients. As a patient for many years, I have consistently experienced outstanding service, with him taking the time to listen and help his patients with the support they need.
    Sep 13, 2024
    Dr. Sabatino continues to provide superb medical intervention coupled with clear explanations presented in a highly assuring context that brings considerable comfort to the patient.
    Sep 06, 2024
    Dr. Sabatino is exceptional!
    Jun 07, 2024
    Dr Sabatino is a great listener. I feel privileged to be his patient. The above marks reflect that.
    May 20, 2024
    Dr. Sabatino always is very caring and considerate, I love that my appts never feel rushed and he answers all of my questions.
    May 19, 2024
    Dr. Sabatino continues to excel in providing stellar care and comfort.
    Mar 18, 2024
    Always good.....thank you for your services
    Dec 15, 2023
    Dr Sabatino, his dept & team and any complimentary dept have always made me feel well cared for in every way!!
    Nov 20, 2023
    Dr, Sabatino is an exceptional provider!
    Oct 27, 2023
    Dr. Sabatino is great at listening and being a MS activist.
    Aug 22, 2023
    Excellent medical care. Extremely knowledgeable, accommodating and patient.
    Jul 31, 2023
    I have had (and continue to have) some awful experiences at UCSF but Dr Sabatino is helping to restore my faith in the medical system.
    May 31, 2023
    Great

    Selected research

    See all research
    Decorative Caduceus

    Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis

    Percent reduction in B cells and T cell subsets in lymphoid tissue of MS patients following ocrelizumab treatment.

    Recruiting

    Contact me

    Share